In the early 2000s, OPCML was clearly shown to be silenced in the majority of ovarian cancer cases (via Knudson two-hit loss consisting of chromosomal loss (LOH) and somatic DNA methylation of two promoter CpG islands) [3,4,5,6]. Here, OPCML is linked to ovarian cancer.